Načítá se...
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...
Uloženo v:
| Vydáno v: | Drugs R D |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995787/ https://ncbi.nlm.nih.gov/pubmed/29546602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0230-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|